Understanding how chaperone proteins affect tau protein in Alzheimer's disease
Probing the Role of Chaperone-TPR Complexes in Tau Proteostasis
This study is looking at how certain proteins in our cells help manage another protein called tau, which is important in Alzheimer's disease, to find new ways to treat patients with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10875700 on NIH RePORTER |
What this research studies
This research investigates the role of molecular chaperones, specifically heat shock proteins Hsp70 and Hsp90, in regulating the modifications of tau protein, which is crucial in the development of Alzheimer's disease and other neurodegenerative disorders. By exploring how these chaperones interact with tau and the enzymes that modify it, the study aims to uncover mechanisms that could restore the balance of tau modifications. The research employs advanced techniques like cryo-electron microscopy and peptide libraries to analyze these interactions at a molecular level, potentially leading to new therapeutic strategies for patients with Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related neurodegenerative disorders.
Not a fit: Patients with other forms of dementia that do not involve tau protein accumulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that help manage or slow the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in targeting tau protein modifications, indicating potential for success in this area.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Gestwicki, Jason E — University of California, San Francisco
- Study coordinator: Gestwicki, Jason E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.